NeuroOne Medical Tech (NASDAQ:NMTC) is preparing to release its quarterly earnings on Tuesday, 2026-02-17. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect NeuroOne Medical Tech to report an earnings per share (EPS) of $-0.04.
Anticipation surrounds NeuroOne Medical Tech's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Performance in Previous Earnings
Last quarter the company missed EPS by $0.00, which was followed by a 7.2% increase in the share price the next day.
Here's a look at NeuroOne Medical Tech's past performance and the resulting price change:
| Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| EPS Estimate | -0.04 | 0.00 | ||
| EPS Actual | -0.04 | -0.03 | -0.07 | 0.06 |
| Price Change % | 7.00 | -1.00 | 2.00 | 2.00 |
Performance of NeuroOne Medical Tech Shares
Shares of NeuroOne Medical Tech were trading at $0.7541 as of February 12. Over the last 52-week period, shares are down 29.9%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for NeuroOne Medical Tech visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
- No comments yet. Be the first to comment!